Atom Investors LP Aerie Pharmaceuticals Inc Transaction History

Atom Investors LP

  • $906 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$18.41 - $28.0 $4.49 Million - $6.84 Million
-244,145 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$28.97 - $48.21 $3.64 Million - $6.06 Million
125,606 Added 105.96%
244,145 $7.21 Million
Q1 2019

May 15, 2019
BUY
$36.32 - $49.25 $865,251 - $1.17 Million
23,823 Added 25.15%
118,539 $5.63 Million
Q4 2018

Feb 14, 2019
BUY
$33.0 - $60.04 $3.13 Million - $5.69 Million
94,716 New
94,716 $3.42 Million

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email